Department of Cardiology, Fukuoka Tokushukai Medical Center, 4-5 Sugu-kita, Kasuga City, Fukuoka 816-0864, Japan.
Abstract:
This clinical pilot study was a randomized, controlled, open-label study in 80 patients with acute myocardial infarction and was designed to examine the effects of a novel free radical scavenger, edaravone. Administration of edaravone before myocardial reperfusion was associated with smaller enzymatic infarcts and better clinical outcome.